NaoTrac has been applied successfully across a wide spectrum of neurosurgical procedures, including biopsy and tumor ablation, ICH, endoscopic surgery, EVD, trigemina! nerve interventions, SRF, SEEG, DBS, and targeted delivery. Its versatility makes it a valuable platform for both routine and highly complex neurosurgical procedure.
Recognized for meeting the highest international standards, NaoTrac has been cleared by the U.S. FDA, obtained the CE Mark in Europe, and received approval from the Taiwan FDA. These regulatory achievements highlight Brain Navi Biotechnology’s commitment to delivering safe, effective, and globally trusted surgical innovations.
>> Visit Brain Navi at MEDICA 2025: Hall 16, A13-1~3
Source: Brain Navi